ArticleJournal of neuro-oncology2014

Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma.

Mohamed A Hamza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.